by Steven Lippmann, MD, and Malathi Latha Perugula, MD The authors are from the Department of Psychiatry and Behavioral Science, University of Louisville School of Medicine, Louisville, Kentucky. Innov Clin
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma van Eijndhoven, MS, MA; Clement Francois, PhD; Crystal Henderson, PharmD, BCPP; and Leslie
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President of Risk Management at PRMS, Inc., Arlington, Virginia. Innov Clin Neurosci. 2016;13(7–8):41–44. This ongoing column is dedicated to providing information
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label
by Arshya Vahabzadeh, MD; Ned Sahin, PhD; and Amir Kalali, MD Dr. Vahabzadeh is Director of Digital Health, Brain Power, in Cambridge, Massachusetts; Instructor in Psychiatry, Harvard Medical School in
by Kai MacDonald, MD, and Katherine Pappas, BA Dr. MacDonald and Ms. Pappas are with UC San Diego Psychiatry, San Diego, CA, USA Innov Clin Neurosci. 2016;13(3–4):13–22. Funding: Dr. MacDonald’s
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Farid Talih, MD, and Jean Ajaltouni, MD Dr. Talih is an assistant professor and Dr. Ajaltouni is a research fellow at the American University of Beirut Medical Center Department
by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada Kasaraneni, MBBS; Christiane S. Hampe, PhD; and Anita H. Clayton, MD Dr. Yarlagadda is Chief of Psychiatry, Behavioral Health Services,
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima, Japan; and Dr. Nagamine is with the
Dear Editor: Adherence to recommendations provided by healthcare professionals to patients is of keen importance to salutary outcomes. However, patients may, for a number of reasons, be nonadherent. Given that
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Irismar Reis de Oliveira, MD, PhD; Camila Seixas, PhD; Flávia L. Osório, PhD; José Alexandre S. Crippa, MD, PhD; José Neander de Abreu, PhD; Igor Gomes Menezes, PhD; Aileen
by Katie Steen, MD; Puneet Narang, MD; and Steven Lippmann, MD Dr. Steen is psychiatry resident at the University of Minnesota, Minneapolis; Dr. Narang is Staff Physician and Lead ECT
The latest in neuroscience—sorted and summarized for you
by Sriram Ramaswamy, MD; Vithyalakshmi Selvaraj, MBBS; David Driscoll, PhD; Jayakrishna S. Madabushi, MD, MRCPsychiatry; Subhash C. Bhatia, MD; and Vikram Yeragani, MBBS, DPM, FRCP(C) Drs. Ramaswamy, Driscoll, and Bhatia
by Rajshekhar Bipeta, MBBS, DPM, DNB (psych); Srinivasa SRR Yerramilli, MD (psych); Ashok Reddy Karredla, MD (psych); and Srinath Gopinath, MBBS, DPM Dr. Bipeta is a consultant psychiatrist from Rajasri
by Mitali Wadekar, MD; Anil Sharma, MD, MBA; and Gina Battaglia, PhD Drs. Wadekar and Sharma are with IRB Company, Inc., Buena Park, California, and Dr. Bittaglia is an independent
